Gherghe, Ana Maria
Dougados, Maxime
Combe, Bernard
Landewé, Robert
Mihai, Carina
Berenbaum, Francis
Mariette, Xavier
Wolterbeek, Ron
van der Heijde, Désirée
Clinical trials referenced in this document:
Documents that mention this clinical trial
Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort
https://doi.org/10.1136/rmdopen-2021-001685
Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort
https://doi.org/10.1136/annrheumdis-2019-216218
Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort
https://doi.org/10.1136/ard-2023-225184
Can power Doppler ultrasound of the entheses help in classifying recent axial spondyloarthritis? Data from the DESIR cohort
https://doi.org/10.1136/rmdopen-2018-000686
Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis
https://doi.org/10.1136/annrheumdis-2017-212008
Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts
https://doi.org/10.1136/rmdopen-2015-000128
THU0353 Change in mri structural lesions in the sacroiliac joint after two years of etanercept therapy in comparison to a contemporary control cohort in non-radiographic axial spondyloarthritis
https://doi.org/10.1136/annrheumdis-2017-eular.1864
Disease activity trajectories in early axial spondyloarthritis: results from the DESIR cohort
https://doi.org/10.1136/annrheumdis-2016-209785
Evaluation of long-term TNFi effectiveness after a first switch in early axial spondyloarthritis considering time-varying prescription bias: an inverse-probability weighting analysis of the DESIR cohort
https://doi.org/10.1136/rmdopen-2021-001846
THU0382 Change in sacroiliac joint structural radiographic damage after two years of etanercept therapy in comparison to a contemporary control cohort in non-radiographic axial spondyloarthritis
https://doi.org/10.1136/annrheumdis-2017-eular.1860
Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years
https://doi.org/10.1136/rmdopen-2021-001986
FRI0216 Detection of structural lesions on t1 weighted mri versus radiography of the si joints in early axial spondyloarthritis: 2-year data
https://doi.org/10.1136/annrheumdis-2018-eular.2124
Different disease activity trajectories in early axial spondyloarthritis lead to significantly different long-term outcomes: a trajectory-based analysis of the DESIR cohort over 10 years
https://doi.org/10.1136/rmdopen-2024-004910
OP0199 Sustained remission of inflammation is associated with reduced structural damage on sacroiliac joint magnetic resonance imaging in patients with early axial spondyloarthritis: evidence to support the concept of treat-to-target
https://doi.org/10.1136/annrheumdis-2018-eular.1114
Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort
https://doi.org/10.1136/rmdopen-2024-004484
Impact of disease outcomes on the Assessment of SpondyloArthritis International Society Health Index (ASAS HI): a Bayesian network analysis of the DESIR cohort
https://doi.org/10.1136/rmdopen-2023-003587
Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort
https://doi.org/10.1136/annrheumdis-2017-211596